On the basis of these results, the researchers propose a molecular stratification of glioblastoma consisting of four clinically relevant tumor subtypes—classical, mesenchymal, proneural and neural.
Despite the progress in our understanding of the process of angiogenesis and the potential of targeting these processes for the treatment of GBM, many challenges remain. Considerations regarding ...
There are 130 different types of brain tumour. The most common in adults is called glioblastoma multiforme. – What is a ...
Then my radiation oncologist asked if I’d be interested in trying a medical device called Optune® for the treatment of glioblastoma multiforme (GBM) and walked me through the risks and benefits.
Glioblastoma multiforme is the most common type of malignant ... My beloved uncle only made it one year after his diagnosis.
A Ludwig Cancer Research study has discovered that recurrent tumors of the aggressive brain cancer glioblastoma multiforme (GBM) grow out of the fibrous scars of malignant predecessors destroyed ...
Kazia Therapeutics Limited (NASDAQ: KZIA) has been making significant strides in its development of paxalisib for glioblastoma multiforme, and recent market data reflects growing investor optimism.
Based on an impressive response rate compared with that of historical controls, bevacizumab (Avastin®; Genentech, CA, USA) received accelerated approval by the US FDA for recurrent GBM in May 2009.